TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Co-Infection
Study results from S. Swaminathan and colleagues update understanding of HIV/AIDS co-infection
March 18th, 2008
According to a study from Madras, India, "An increase in tuberculosis (TB) incidence has been associated with human immunodeficiency virus (HIV). To describe the clinical characteristics and treatment outcome of patients with HIV and miliary TB treated with short-course intermittent chemotherapy in the absence of access to highly active antiretroviral therapy (HAART)." "Prospective study of HIV infected adults referred to a TB clinic between July 1999 and July 2004. On diagnosis of miliary TB, patients were treated with a standard regimen of two months of isoniazid, rifampicin, ethambutol and pyrazinamide followed by four months of isoniazid and rifampicin...
Source: TB & Outbreaks Week (2008-03-18)
|
